177 related articles for article (PubMed ID: 32515651)
1. Clinical characteristics of foreign-imported COVID-19 cases in Shanghai, China.
Liu XH; Lu SH; Chen J; Xia L; Yang ZG; Charles S; Yang Y; Lin Y; Lu HZ
Emerg Microbes Infect; 2020 Dec; 9(1):1230-1232. PubMed ID: 32515651
[No Abstract] [Full Text] [Related]
2. Successful use of methylprednisolone for treating severe COVID-19.
Liu J; Zheng X; Huang Y; Shan H; Huang J
J Allergy Clin Immunol; 2020 Aug; 146(2):325-327. PubMed ID: 32479759
[No Abstract] [Full Text] [Related]
3. Patterns of IgG and IgM antibody response in COVID-19 patients.
Liu X; Wang J; Xu X; Liao G; Chen Y; Hu CH
Emerg Microbes Infect; 2020 Dec; 9(1):1269-1274. PubMed ID: 32515684
[No Abstract] [Full Text] [Related]
4. COVID-19: Small-Molecule Clinical Trials Landscape.
Ferreira LLG; Andricopulo AD
Curr Top Med Chem; 2020; 20(18):1577-1580. PubMed ID: 32862824
[No Abstract] [Full Text] [Related]
5. Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19.
Omarjee L; Janin A; Perrot F; Laviolle B; Meilhac O; Mahe G
Clin Immunol; 2020 Jul; 216():108464. PubMed ID: 32405269
[No Abstract] [Full Text] [Related]
6. Clinicolaboratory study of 25 fatal cases of COVID-19 in Wuhan.
Tu WJ; Cao J; Yu L; Hu X; Liu Q
Intensive Care Med; 2020 Jun; 46(6):1117-1120. PubMed ID: 32253448
[No Abstract] [Full Text] [Related]
7. Tocilizumab treatment in COVID-19: A single center experience.
Luo P; Liu Y; Qiu L; Liu X; Liu D; Li J
J Med Virol; 2020 Jul; 92(7):814-818. PubMed ID: 32253759
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 positivity in a discharged COVID-19 patient: a case report.
Li J; Long X; Fang X; Zhang Q; Hu S; Lin Z; Xiong N
Clin Microbiol Infect; 2020 Aug; 26(8):1115-1117. PubMed ID: 32360448
[No Abstract] [Full Text] [Related]
9. Coronavirus disease 2019 in patients with HIV in the province of Araba, Basque Country, Spain.
Molina-Iturritza E; San-José-Muñiz I; Ganchegui-Aguirre M; Balerdi-Sarasola L; Ortiz-de-Zárate-Ibarra Z; Gainzarain-Arana JC; Portu-Zapirain J
AIDS; 2020 Sep; 34(11):1696-1697. PubMed ID: 32769770
[No Abstract] [Full Text] [Related]
10. Leukotrienes, a potential target for Covid-19.
Citron F; Perelli L; Deem AK; Genovese G; Viale A
Prostaglandins Leukot Essent Fatty Acids; 2020 Oct; 161():102174. PubMed ID: 32977289
[No Abstract] [Full Text] [Related]
11. Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach.
Sarma P; Prajapat M; Avti P; Kaur H; Kumar S; Medhi B
Indian J Pharmacol; 2020; 52(1):1-5. PubMed ID: 32201439
[No Abstract] [Full Text] [Related]
12. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z
Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulation in COVID-19.
Ingraham NE; Lotfi-Emran S; Thielen BK; Techar K; Morris RS; Holtan SG; Dudley RA; Tignanelli CJ
Lancet Respir Med; 2020 Jun; 8(6):544-546. PubMed ID: 32380023
[No Abstract] [Full Text] [Related]
14. World War against COVID-19: How strong is our armamentarium?
Ramachandran V; Marimuthu RR; Chinnambedu RS
Med J Malaysia; 2020 May; 75(3):314-315. PubMed ID: 32467555
[TBL] [Abstract][Full Text] [Related]
15. Resistance of children to Covid-19. How?
Fischer A
Mucosal Immunol; 2020 Jul; 13(4):563-565. PubMed ID: 32467603
[No Abstract] [Full Text] [Related]
16. Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome.
Okour M; Al-Kofahi M; Austin D
J Pharmacokinet Pharmacodyn; 2020 Jun; 47(3):187-188. PubMed ID: 32405664
[No Abstract] [Full Text] [Related]
17. Potential strategies for combating COVID-19.
Shamim S; Khan M; Kharaba ZJ; Ijaz M; Murtaza G
Arch Virol; 2020 Nov; 165(11):2419-2438. PubMed ID: 32778950
[TBL] [Abstract][Full Text] [Related]
18. Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.
Giovane RA; Rezai S; Cleland E; Henderson CE
Rev Med Virol; 2020 Sep; 30(5):e2136. PubMed ID: 32644275
[TBL] [Abstract][Full Text] [Related]
19. A cross-sectional comparison of epidemiological and clinical features of patients with coronavirus disease (COVID-19) in Wuhan and outside Wuhan, China.
Lei Z; Cao H; Jie Y; Huang Z; Guo X; Chen J; Peng L; Cao H; Dai X; Liu J; Li X; Zhu J; Xu W; Chen D; Gao Z; He JR; Lin BL
Travel Med Infect Dis; 2020; 35():101664. PubMed ID: 32278758
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 outbreak in Iraqi Kurdistan: The first report characterizing epidemiological, clinical, laboratory, and radiological findings of the disease.
Merza MA; Haleem Al Mezori AA; Mohammed HM; Abdulah DM
Diabetes Metab Syndr; 2020; 14(4):547-554. PubMed ID: 32408119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
